ABSTRACT
Introduction: Post COVID care clinic (PCCC) was started in Hospital Sungai Buloh in mid June 2020. Most category 4 and 5 COVID-19 patients would be discharged with a range of medications and will be followed up at PCCC. Some medication requires tapering doses might be burdensome to patients while adverse effects from some medication could also affect compliance. The aims of this study were to review patient clinical characteristics, medication adherence and treatment outcomes to discharge medications. Material(s) and Method(s): A cross sectional study at the PCCC from April 1 to May 21, 2021 was conducted. Patients who attended PCCC and gave consent were included in the study. Assigned pharmacist approached the patient with the case report form and the Malaysia Medication Adherence Assessment Tool (MyMAAT) was self administered by the patient or caregiver. Result(s): A total of 128 patients were included in the study. Majority of patients seen were with co- morbidity hypertension and diabetes. Complications of COVID-19 reported were mostly organizing pneumonia (90%) and pulmonary embolism (43%). Most patients (91%) discharged with at least one medication and anti-inflammatory was the most commonly prescribed (93%). Oral prednisolone and dexamethasone were prescribed over several days to weeks in the treatment of organizing pneumonia. Patients on anti- inflammatory reported the highest adverse drug reactions (93%). Overall adherence to discharge medications in the PCCC was good (76%). However, there could be potential for under-reporting of side effects experiences for one or more of discharge medications as a result of completed treatment. Conclusion(s): This was the first study done specifically to review the discharge medications in a PCCC. Good adherence was shown despite several adverse drug effects reported by post COVID-19 patients.